Bill Texts: NY S08038 | 2023-2024 | General Assembly

Bill Title: Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-01-29 - SUBSTITUTED BY A8501 [S08038 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2024-01-05HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New York S08038

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New York S08038 currently on file.

Social Comments on NY S08038

feedback